Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duo: Integrated Strategy of HIV PrEP and STI PEP for Young Men
NCT07658976Phase 3Not yet recruiting
- Sponsor
- HIV Prevention Trials Network
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by HIV Prevention Trials Network. Primary endpoints: PrEP uptake at 52 weeks, PrEP adherence at 52 weeks and 4 more. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07658976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658976.